FindTrial
Sign In

Research on the Mechanism of Moxibustion Treatment for Vitiligo

Study on the mechanism of moxibustion regulating SCF/c-kit signalingpathway in the treatment of vitiligo based on M1/M2 polarization of peripheral blood macrophages

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001946
Enrollment
Unknown
Registered
2025-10-15
Start date
2025-04-01
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vitiligo

Interventions

Moxibustion group:moxibustion

Sponsors

Beijing Hospital of Traditional Chinese Medicine Affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: A) Meets the diagnostic criteria for stable and localized vitiligo with a target lesion area less than 5% of the body surface area; B) Age between 18-65 years old gender not limited; C) Those who voluntarily participate in this study and sign the informed consent form

Exclusion criteria

Exclusion criteria: A) Suffering from severe mental illness cognitive impairment and lack of personal behavioral ability not suitable for participating in clinical research B) Other reasons: Researchers believe that it is not appropriate to participate in this study C) Patients who have received treatment in the past three months have liver and kidney function that does not meet the requirements.

Design outcomes

Primary

MeasureTime frame
Skin lesion scoring criteria (VASI score);Transcriptomic analysis;—

Countries

CHINA

Contacts

Public ContactYU CHENG

Beijing Hospital of Traditional Chinese Medicine Affiliated to Capital Medical University

yucheng7586@126.com15801120034

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026